Quality Level
grade
certified reference material, pharmaceutical secondary standard
agency
USP 1013002, traceable to Ph. Eur. A0350000
API family
allopurinol
CofA
current certificate can be downloaded
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
mp
>300 °C (lit.)
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-30°C
SMILES string
O=C1NC=Nc2[nH]ncc12
InChI
1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)
InChI key
OFCNXPDARWKPPY-UHFFFAOYSA-N
Gene Information
human ... XDH(7498)
General description
用于质量控制的药物二级标准品,为制药实验室和制造商制备内部工作标准品提供了一种方便、高性价比的替代方案。
别嘌醇是一种用于治疗慢性痛风或高尿酸血症的药物。它的作用方式涉及抑制黄嘌呤氧化酶,黄嘌呤氧化酶是催化次黄嘌呤羟基化为黄嘌呤和黄嘌呤羟基化为尿酸的重要酶。
别嘌醇是一种用于治疗慢性痛风或高尿酸血症的药物。它的作用方式涉及抑制黄嘌呤氧化酶,黄嘌呤氧化酶是催化次黄嘌呤羟基化为黄嘌呤和黄嘌呤羟基化为尿酸的重要酶。
Application
别嘌醇可用作药物标准品,通过色谱技术测定药物制剂中的分析物。
这些二级标准品是合格的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。
Biochem/physiol Actions
黄嘌呤氧化酶和初始嘧啶生物合成的抑制剂。治疗高尿酸血症和痛风的经典药物。
Analysis Note
These secondary standards offer multi-traceability to the USP and EP primary standards, where they are available.
Other Notes
想要查看本品的检验报告示例,请在下框中输入LRAA1633。这只是一个示例证书,可能与您收到的批次不符。
该认证标准物质(CRM)根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在检验报告上找到。
Still not finding the right product?
Explore all of our products under 别嘌醇
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Oral - Skin Sens. 1
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
相关内容
默克Supelco®标准物质不断推出或更新满足海关及法规要求的标准物质。每年我们约有上百种的新CRM或标准物质上市,在此我们尽可能多的列出满足海关及法规要求的标准物质。
Spectrophotometric determination of Allopurinol in tablet formulation.
Khayoon WShakir, et al.
Journal of Physical Science, 19(2), 23-30 (2008)
Spectrophotometric determination of allopurinol drug in tablets: Spectroscopic characterization of the solid CT complexes.
Refat MS, et al.
Bull. Korean Chem. Soc., 31(6), 1535-1542 (2010)
Stephanie Peglow et al.
Journal of hepato-biliary-pancreatic sciences, 18(2), 137-146 (2010-09-30)
Allopurinol was first introduced, in 1963, as a xanthine oxidase inhibitor when it was investigated for concomitant use with cancer chemotherapy drugs. Today it is used in gout and hyperuricemia. Due to its additive benefit in preventing oxidative damage, attention
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| PHR1377-1G | 04061834416180 |
